BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3457232)

  • 1. Membrane HLADr (Ia-like) and cytoplasmic chloroacetate esterase expression by blast cells in myeloid leukaemia.
    Scott CS; Limbert HJ
    Med Lab Sci; 1986 Jan; 43(1):88-90. PubMed ID: 3457232
    [No Abstract]   [Full Text] [Related]  

  • 2. Serological detection of B-cell ("Ia-like") antigens in serum of normal donor and in some sera of leukaemic patients.
    Koubek K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(3):408-15. PubMed ID: 6182060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies.
    Stöckbauer P; Malasková V; Soucek J; Chudomel V
    Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic phenotype of blast cells in the diagnosis of myeloblastic leukemias].
    Baryshnikov AIu; Volkova MA; Frenkel' MA; Tupitsyn NN; Morozova LF
    Ter Arkh; 1985; 57(5):98-100. PubMed ID: 3895550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficient expression of MHC class II antigens in some cases of human B cell leukaemia.
    Guy K; Docherty LJ; Dewar AE
    Clin Exp Immunol; 1986 Feb; 63(2):290-7. PubMed ID: 3486060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M; Kusenda J; Babusikova O
    Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinico-morphological characteristics of immunological variants of the blast crisis in myelocytic leukemia].
    Baryshnikov AIu; Morozova LF; Volkova MA; Frenkel' MA; Frinovskaia IV
    Gematol Transfuziol; 1985 Nov; 30(11):12-6. PubMed ID: 3866721
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of HLA-DR antigens on leukaemic cells.
    Newman RA; Greaves MF
    Clin Exp Immunol; 1982 Oct; 50(1):41-50. PubMed ID: 6959750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate.
    Guy K; Meehan RR; Dewar AE; Larhammar D
    Immunology; 1986 Feb; 57(2):181-8. PubMed ID: 3512424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DR positive cells in the human placenta.
    Sutton L; Mason DY; Redman CW
    Immunology; 1983 May; 49(1):103-12. PubMed ID: 6220962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histochemical discrimination of HLA-DR positive cell populations in the normal and arthritic synovial lining.
    Poulter LW; Duke O; Hobbs S; Janossy G; Panayi G
    Clin Exp Immunol; 1982 May; 48(2):381-8. PubMed ID: 6213328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetics and flow cytometry may predict phenotype of CML blast crisis.
    Ligler FS; Brodsky I; Schlam ML; Fuscaldo KE
    Cancer Detect Prev; 1985; 8(1-2):317-23. PubMed ID: 3864537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane Fc-IgG and C3b receptors on myeloid leukaemia cells: a comparison with cytoplasmic acid naphthyl acetate esterase cytochemistry.
    Scott CS; Bynoe AG; Linch DC; Allen C; Hough D; Roberts BE
    J Clin Pathol; 1983 May; 36(5):555-8. PubMed ID: 6221035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Ia like (HLA-DR) antigens on human alveolar macrophages.
    Clerici N; Reboiras S; Fierro C; Leyva-Cobian F
    Clin Exp Immunol; 1984 Nov; 58(2):388-94. PubMed ID: 6209043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry.
    Burchiel SW; Martin JC; Imai K; Ferrone S; Warner NL
    Cancer Res; 1982 Oct; 42(10):4110-5. PubMed ID: 7049355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting antigenic maturation patterns in M0-M2 versus M3 acute myeloid leukemias.
    Lewis RE; Cruse JM; Webb RN; Sanders CM; Beason K
    Exp Mol Pathol; 2007 Oct; 83(2):269-73. PubMed ID: 17603036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Report from the International Bone Marrow Transplant Registry, 1984.
    Exp Hematol; 1985 Aug; 13(7):709-14. PubMed ID: 3896831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of HLA-DR structure and a membrane-specific antigen by a granulocytopoietic line of acute leukemic blast cells].
    Palumbo A; Giovinazzo B; Marmont F; Garbarino G; Paolino F; Pegoraro L
    Boll Soc Ital Biol Sper; 1982 Mar; 58(6):271-4. PubMed ID: 6952888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of HLA-DR antigens (Ia-like antigens) in the cornea].
    Gronemeyer U; Stein H; Gerdes J
    Fortschr Ophthalmol; 1983; 80(4):345-7. PubMed ID: 6354897
    [No Abstract]   [Full Text] [Related]  

  • 20. Cloned human interferon-gamma, but not interferon-beta or -alpha, induces expression of HLA-DR determinants by fetal monocytes and myeloid leukemic cell lines.
    Kelley VE; Fiers W; Strom TB
    J Immunol; 1984 Jan; 132(1):240-5. PubMed ID: 6418799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.